Anthony Russell

A.Professor of Medicine

University of Queensland

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anthony Russell is an Associate Professor of Medicine at the University of Queensland, Australia. His research focuses on diabetes management, including diabetes distress screening, the efficacy of treatments such as semaglutide, and the complications associated with diabetes mellitus. He has also contributed to studies on cardiovascular risk management in diabetic patients and the use of magnetic resonance imaging in clinical settings.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (16)

Steve Kisely

AUSTRALIA

Anthony Russell

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis: Study protocol for a Phase-3 cluster-crossover, blinded, randomised, controlled trial

Fulminant pancreatogenic diabetes following upper abdominal irradiation

Diabetes distress screening using PAID‐5 and PAID‐1 among adults attending a tertiary multidisciplinary type 1 diabetes clinic

Diabetes distress screening using PAID-5 and PAID-1 among adults attending a tertiary multidisciplinary type 1 diabetes clinic

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia

The Utility of Magnetic Resonance Imaging for Hypophysitis Secondary to Immune Checkpoint Inhibitor Use

The management of cardiovascular risk in people with diabetes: Insights from an audit of health services providing diabetes care

Cardiovascular effects of tirzepatide

The growing range of complications of diabetes mellitus

Are people with diabetes mHealth-ready? Smartphone utilisation in a socioeconomically marginalised urban Australian general practitioner-led diabetes clinic

Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023

Cardiovascular and metabolic risk incidence among adult allogeneic stem cell transplant recipients: a narrative review

Cardiovascular and metabolic risk incidence among adult allogeneic stem cell transplant recipients: a narrative review

Working Together to Improve Type 2 Diabetes Care: A Participatory Design Project to Address Identified Needs of People With Diabetes and Their Health-care Professionals

Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST)

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review

Secular trends in the utility of SGLT-2 inhibitors in heart failure patients with type 2 diabetes mellitus across Metro South Health hospitals in South-East Queensland

Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism

Digital interventions to improve safety and quality of inpatient diabetes management: A systematic review

Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study.

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests

Electronic consultations ( eConsults ): a proof of concept trial in Australia

Toilet Paper, Minced Meat and Diabetes Medicines: Australian Panic Buying Induced by COVID-19

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: Costing analysis

Same goals, different challenges: A systematic review of perspectives of people with diabetes and healthcare professionals on Type 2 diabetes care

Collaborators (16)

Steve Kisely

Soraia de Camargo Catapan

Ella Zomer

Elizabeth Powell

Patricia C. Valery

Befikadu Legesse Wubishet

Katharine M. Irvine

Arul Earnest

Nicola Warren

Fay Probert

Stephen Ignatius Lentz

Mitra Tavakoli

Bala Venkatesh

Dolly Baliunas

Steven Trawley

Gail A. Robinson

Make your next move.